Pharmacological inhibiting STAT5 for the treatment of FLT3-ITD-positive acute myeloid leukemia with triciribine phosphate monohydrate

被引：2
|
作者：
Wu, Hong [1 ,2 ]
Ge, Juan [1 ,3 ]
Zou, Fengming [1 ,2 ]
Jiang, Zongru [1 ]
Wang, Beilei [1 ,2 ]
Yuan, Xinyu [1 ,3 ]
Long, Kaili [1 ,3 ]
Liu, Jing [1 ,2 ,3 ,4 ]
Wang, Wenchao [1 ,2 ,3 ,4 ]
Liu, Qingsong [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei, Anhui, Peoples R China
[2] Chinese Acad Sci, Hefei Canc Hosp, Hefei, Anhui, Peoples R China
[3] Univ Sci & Technol China, Hefei, Anhui, Peoples R China
[4] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China
来源：
MEDCOMM | 2023年 / 4卷 / 04期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/mco2.294
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
    Tecik, Melisa
    Adan, Aysun
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (06) : 719 - 751
  • [32] Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes
    Ersoz, Nur Sebnem
    Adan, Aysun
    MEDICAL ONCOLOGY, 2022, 39 (03)
  • [33] PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
    Islam Alshamleh
    Nina Kurrle
    Philipp Makowka
    Raj Bhayadia
    Rahul Kumar
    Sebastian Süsser
    Marcel Seibert
    Damian Ludig
    Sebastian Wolf
    Sebastian E. Koschade
    Karoline Stoschek
    Johanna Kreitz
    Dominik C. Fuhrmann
    Rosa Toenges
    Marco Notaro
    Federico Comoglio
    Jan Jacob Schuringa
    Tobias Berg
    Bernhard Brüne
    Daniela S. Krause
    Jan-Henning Klusmann
    Thomas Oellerich
    Frank Schnütgen
    Harald Schwalbe
    Hubert Serve
    Leukemia, 2023, 37 : 2367 - 2382
  • [34] Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes
    Nur Şebnem Ersöz
    Aysun Adan
    Medical Oncology, 2022, 39
  • [35] Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
    Levis, Mark
    FUTURE ONCOLOGY, 2014, 10 (09) : 1571 - 1579
  • [36] PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
    Alshamleh, Islam
    Kurrle, Nina
    Makowka, Philipp
    Bhayadia, Raj
    Kumar, Rahul
    Suesser, Sebastian
    Seibert, Marcel
    Ludig, Damian
    Wolf, Sebastian
    Koschade, Sebastian E.
    Stoschek, Karoline
    Kreitz, Johanna
    Fuhrmann, Dominik C.
    Toenges, Rosa
    Notaro, Marco
    Comoglio, Federico
    Schuringa, Jan Jacob
    Berg, Tobias
    Bruene, Bernhard
    Krause, Daniela S.
    Klusmann, Jan-Henning
    Oellerich, Thomas
    Schnuetgen, Frank
    Schwalbe, Harald
    Serve, Hubert
    LEUKEMIA, 2023, 37 (12) : 2367 - 2382
  • [37] Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
    K D Cummins
    S M Jane
    S Ninkovic
    A Bazargan
    R Filshie
    G Sutrave
    M Hertzberg
    A Scott
    S Lane
    C K Yannakou
    D Ritchie
    J D'Rozario
    J Black
    K Bavishi
    A Wei
    Blood Cancer Journal, 2014, 4 : e246 - e246
  • [38] Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
    Hu, Chen
    Zou, Fengming
    Wang, Aoli
    Miao, Weili
    Liang, Qianmao
    Weisberg, Ellen L.
    Wang, Yinsheng
    Liu, Jing
    Wang, Wenchao
    Liu, Qingsong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [39] ABCB6 RNA expression in leukemias-expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia
    Abraham, Ajay
    Karathedath, Sreeja
    Varatharajan, Savitha
    Markose, Preetha
    Chendamarai, Ezhilarasi
    Jayavelu, Ashok Kumar
    George, Biju
    Srivastava, Alok
    Mathews, Vikram
    Balasubramanian, Poonkuzhali
    ANNALS OF HEMATOLOGY, 2014, 93 (03) : 509 - 512
  • [40] Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD-positive acute myeloid leukemia
    Lo Iudice, Gabriele
    De Bellis, Eleonora
    Savi, Arianna
    Guarnera, Luca
    Massacci, Alice
    De Nicola, Francesca
    Goeman, Frauke
    Ottone, Tiziana
    Divona, Mariadomenica
    Pallocca, Matteo
    Fanciulli, Maurizio
    Voso, Maria Teresa
    Ciliberto, Gennaro
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
12345